VIM and B-cell chronic lymphocytic leukemia: To corroborate the finding that vimentin functions as an antigen recognized by stereotyped CLL BCRs of subset 1, we further explored its interaction with a broader range of protein extracts from stromal and control cells and correlated it with the interaction pattern of a commercially available anti-vimentin antibody.